DexCom, Inc. - Common Stock - Nakit Akışı (NASDAQ:DXCM)

Financials

İşletme faaliyetlerinden elde edilen nakit 475.6 M442.5 M669.5 M748.5 M989.5 M1.44 B 1.78 B Yatırım faaliyetlerinden elde edilen nakit -1.02 B-216.1 M-521.5 M-507.2 M-207.5 M536 M 137.3 M Finansman faaliyetlerinden elde edilen nakit 912.1 M10.4 M-552.5 M-318.6 M-734.8 M-1.69 B -1.72 B Serbest nakit akışı 475.6 M442.5 M669.5 M748.5 M989.5 M1.08 B 1.43 B

DexCom, Inc. - Common Stock

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.

DXCM

Financials

DexCom, Inc. - Common Stock

Haberler

PODD Stock: What a Hold Rating Says at a $163 Target

PODD and Omnipod 5: What's Driving Insulet's 2026 Growth

Why DexCom (DXCM) is a Top Growth Stock for the Long-Term

DexCom Might Finally Be Cheap Enough (NASDAQ:DXCM)

The DexCom Stock Turnaround Is Showing Real Signs of Life

Here's Why DexCom (DXCM) is a Strong Momentum Stock

Top Stock Gainers Today, 5/19/26 - TipRanks.com

DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany

Canaccord, marj görünümü nedeniyle DexCom hisse hedefini düşürdü

Stocks Set to Open Lower as Oil Rises Amid Iran Impasse, Nvidia Earnings and Fed Minutes Awaited

DexCom, Inc. (DXCM) Analyst/Investor Day - Slideshow (NASDAQ:DXCM) 2026-05-17

Morning News Wrap-Up, 5/15/26: Today’s Biggest Stock Market Stories! - TipRanks.com